[MacMillan] has big shoes to fill and he's inheriting a legacy of 20% earnings growth. |
I don't see material upside or downside (for Boston Scientific shares) for the next 12 months. |
I think a lot of folks had not expected them to be back this quickly. |
I would venture that we are now outside of gentlemanly territory, |
If the deals went to shareholders today, we believe Boston Scientific would prevail. |
If they do negotiate a lower price, they may open themselves up to litigation by essentially conceding that there has been a problem under management's watch, |
If they do negotiate a lower price, they may open themselves up to litigation by essentially conceding that there has been a problem under management's watch. |
It they found somebody who could clean up ship a little, it sends a message. |
It's probably the biggest thing that happened in the medical devices [industry] in the last 10 years. |
The deal will proceed if J&J will get the price it wants. I am not sure Guidant will give them that price. |
The fact that they found something else is not a concern. It's almost to be expected. When a policeman pulls you over for speeding and decides to look around your car, there's a good likelihood that if he wants to, he can find something to give you a citation for. |
They are buying a crown jewel and they are getting it at a reasonable valuation. |
This is a very simple integration. It should not be difficult. |
This offer is superior. This offer promises a higher price, stock with better appreciation potential, commitments to do what it takes to avoid antitrust concerns, and a firm timeline. |
We are operating in a large vacuum. It's exceedingly difficult to speculate. |